CTXR EPS Estimates
Citius Pharmaceuticals, Inc.
$0.47
-$0.01(-2.31%)
30
Overall
60
Value
10
Tech
21
Quality
Market Cap
$12.77M
Volume
233.51K
52W Range
$0.47 - $2.19
Target Price
$4.00
CTXR EPS estimates: the consensus estimate for Citius Pharmaceuticals, Inc.'s current fiscal year is -$2.03 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CTXR EPS Estimates
- EPS estimate, current quarter
- $-0.41
- EPS estimate, next quarter
- $-0.38
- EPS estimate, current year
- $-2.03
- EPS estimate, next year
- $-1.44
- EPS growth, 3-year
- +16.23%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.38 |
| 2024 | $-5.97 |
| 2023 | $-5.50 |
| 2022 | $-5.75 |
| 2021 | $-5.75 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTXR | $0.47 | -2.3% | 233.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Citius Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW